Lipe & Dalton’s Allergan plc AGN Stock Holding History

Lipe & Dalton’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,204	Closed	-$707K	–	80
2018 Q1	$707K	Buy	+4,204	New	+$705K	0.51%	44

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lipe & Dalton's AGN Position: Q2 2018 in Review

Lipe & Dalton sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 4,204 shares — an estimated $707K sold.

Lipe & Dalton first reported a position in AGN in Q1 2018 and held it in 1 quarter. The position peaked at $707K in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

Lipe & Dalton reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
Lipe & Dalton sold 4,204 Allergan plc shares in Q2 2018, an estimated $707K.
Lipe & Dalton first reported a position in Allergan plc in Q1 2018 and held it in 1 quarter.
Lipe & Dalton's Allergan plc position peaked at $707K in Q1 2018.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Lipe & Dalton's 13F filing for Q2 2018, filed 6 Aug 2018.